Company No: 04054345 (England and Wales)

Contents

• Balance Sheet
• Notes to the Financial Statements

	Note	2024		2023
		£		£
Fixed assets
Tangible assets	3	592,578		534,964
Investments	4	62,500		62,500
		655,078		597,464
Current assets
Stocks	5	629,660		1,396,612
Debtors	6	1,208,428		1,973,717
Cash at bank and in hand		2,015,445		618,496
		3,853,533		3,988,825
Creditors: amounts falling due within one year	7	( 562,103)		( 859,375)
Net current assets		3,291,430		3,129,450
Total assets less current liabilities		3,946,508		3,726,914
Provision for liabilities		( 4,869)		( 47,113)
Net assets		3,941,639		3,679,801
Capital and reserves
Called-up share capital	8	103		103
Profit and loss account		3,941,536		3,679,698
Total shareholders' funds		3,941,639		3,679,801

For the financial year ending 31 December 2024 the Company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

• The members have not required the Company to obtain an audit of its financial statements for the financial year in accordance with section 476;
• The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements; and
• These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime and a copy of the Statement of Income and Retained Earnings has not been delivered.

The financial statements of C J Medical Limited (registered number: 04054345) were approved and authorised for issue by the Board of Directors on 02 July 2025. They were signed on its behalf by:

Mr C R Reynolds Director

1. Accounting policies

The principal accounting policies are summarised below. They have all been applied consistently throughout the financial year and to the preceding financial year, unless otherwise stated.

General information and basis of accounting

C J Medical Limited (the Company) is a private company, limited by shares, incorporated in the United Kingdom under the Companies Act 2006 and is registered in England and Wales. The address of the Company's registered office is Unit B3 Walker Business Park, Three Mile Stone, Truro, TR4 9FB, United Kingdom.

The financial statements have been prepared under the historical cost convention, modified to include the revaluation of freehold properties and to include investment properties and certain items at fair value, and in accordance with Section 1A of Financial Reporting Standard 102 (FRS 102) ‘The Financial Reporting Standard applicable in the UK and Republic of Ireland’ issued by the Financial Reporting Council and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime.

The financial statements are presented in pounds sterling which is the functional currency of the Company and rounded to the nearest £.

Foreign currency

Transactions in foreign currencies are recorded at the rate of exchange at the date of the transaction. Monetary assets and liabilities denominated in foreign currencies at the Balance Sheet date are reported at the rates of exchange prevailing at that date.

Turnover

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of value added tax, returns, rebates and discounts and after eliminating sales within the company.

The company recognises revenue when; the amount of revenue can be reliably measured; it is probable that future economic benefits will flow to the entity; and specific criteria have been met for each of the company's activities.

Taxation

Current tax
Current tax is provided at amounts expected to be paid (or recoverable) using the tax rates and laws that have been enacted or substantively enacted at the Balance Sheet date.

Deferred tax
Deferred tax arises as a result of including items of income and expenditure in taxation computations in periods different from those in which they are included in the Company's financial statements. Deferred tax is provided in full on timing differences which result in an obligation to pay more or less tax at a future date, at the average tax rates that are expected to apply when the timing differences reverse, based on tax rates and laws substantively enacted at the balance sheet date. Deferred tax assets and liabilities are not discounted.

Tangible fixed assets

Tangible fixed assets are stated at cost or valuation, net of depreciation and any provision for impairment. Depreciation is provided on all tangible fixed assets, other than investment property and freehold land, at rates calculated to write off the cost or valuation, less estimated residual value, of each asset on a straight-line basis over its expected useful life, as follows:

Land and buildings	50 years straight line
Plant and machinery	1 - 4 years straight line
Vehicles	4 years straight line
Fixtures and fittings	2 - 4 years straight line

Residual value represents the estimated amount which would currently be obtained from disposal of an asset, after deducting estimated costs of disposal, if the asset were already of the age and in the condition expected at the end of its useful life.

Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to sell, which is equivalent to the net realisable value. Cost is calculated using the FIFO (first-in, first-out) method.

The cost of finished goods and work in progress comprises direct materials and, where applicable, direct labour costs and those overheads that have been incurred in bringing the stocks to their present location and condition. At each reporting date, stocks are assessed for impairment. If stocks are impaired, the carrying amount is reduced to its selling price less costs to complete and sell; the impairment loss is recognised immediately in profit or loss.

Financial instruments

Classification
The company holds the following financial instruments:

• Investments in other financial assets; and
• Short term trade and other debtors and creditors; and
• Cash and bank balances.

All financial instruments are classified as basic.

Recognition and measurement
The company has chosen to apply the recognition and measurement principles in FRS102.

Financial instruments are recognised when the company becomes party to the contractual provisions of the instrument and derecognised when in the case of assets, the contractual rights to cash flows from the assets expire or substantially all the risks and rewards of ownership are transferred to another party, or in the case of liabilities, when the company’s obligations are discharged, expire or are cancelled.

Except for bank loans, such instruments are initially measured at transaction price, including transaction costs, and are subsequently carried at the undiscounted amount of the cash or other consideration expected to be paid or received, after taking account of impairment adjustments.

Bank loans are initially measured at transaction price, including transaction costs, and are subsequently carried at amortised cost using the effective interest method.

Defined contribution pension obligation

A defined contribution plan is a pension plan under which fixed contributions are paid into a pension fund and the company has no legal or constructive obligation to pay further contributions even if the fund does not hold sufficient assets to pay all employees the benefits relating to employee service in the current and prior periods.

Contributions to defined contribution plans are recognised as employee benefit expense when they are due. If contribution payments exceed the contribution due for service, the excess is recognised as a prepayment.

2. Employees

	2024		2023
	Number		Number
Monthly average number of persons employed by the Company during the year, including directors	21		17

3. Tangible assets

	Land and buildings		Plant and machinery		Vehicles		Fixtures and fittings		Total
	£		£		£		£		£
Cost
At 01 January 2024	44,255		907,875		614,512		148,710		1,715,352
Additions	48,762		84,128		338,856		10,180		481,926
Disposals	0		( 13,503)		( 69,272)		0		( 82,775)
At 31 December 2024	93,017		978,500		884,096		158,890		2,114,503
Accumulated depreciation
At 01 January 2024	0		664,000		371,266		145,122		1,180,388
Charge for the financial year	885		211,546		191,472		7,262		411,165
Disposals	0		( 356)		( 69,272)		0		( 69,628)
At 31 December 2024	885		875,190		493,466		152,384		1,521,925
Net book value
At 31 December 2024	92,132		103,310		390,630		6,506		592,578
At 31 December 2023	44,255		243,875		243,246		3,588		534,964

4. Fixed asset investments

	Other investments		Total
	£		£
Cost or valuation before impairment
At 01 January 2024	62,500		62,500
At 31 December 2024	62,500		62,500
Carrying value at 31 December 2024	62,500		62,500
Carrying value at 31 December 2023	62,500		62,500

5. Stocks

	2024		2023
	£		£
Stocks	629,660		1,396,612

6. Debtors

	2024		2023
	£		£
Trade debtors	1,046,130		1,292,845
Amounts owed by directors	200		0
Prepayments	68,970		53,787
Other debtors	93,128		627,085
	1,208,428		1,973,717

7. Creditors: amounts falling due within one year

	2024		2023
	£		£
Trade creditors	44,578		77,903
Amounts owed to directors	0		20,316
Accruals	48,676		4,000
Corporation tax	118,644		521,504
Other taxation and social security	250,468		184,642
Other creditors	99,737		51,010
	562,103		859,375

8. Called-up share capital

	2024		2023
	£		£
Allotted, called-up and fully-paid
103 Ordinary shares of £ 1.00 each	103		103

9. Related party transactions

Transactions with the entity's directors

	2024		2023
	£		£
Advances paid to directors	200		0

Interest free loan repayable on demand.

Other related party transactions

	2024		2023
	£		£
Island View Capital	0		602,903

At the balance sheet date £Nil (2023 - £602,903) was due from a company under common control. The loan was unsecured, interest free and repayable on demand.